ProCE Banner Activity

Newer Immunotherapy Options for Relapsed/Refractory Follicular Lymphoma

Slideset Download

Download this slideset from a live CCO webinar for an expert overview of recent updates in R/R FL with a focus on bispecific antibodies and CAR T-cell therapy, including data from ASH 2022.

Released: February 02, 2023

Expiration: February 01, 2024

Begin Activity



Ian W. Flinn

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

Laurie H. Sehn

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

ProCE Banner


Genentech, a member of the Roche Group

MEI Pharma Inc